info@birdgroup.be

Login

Papers

Clin Gastroenterol Hepatol. 2021 May;19(5):947-954.e2.
Infliximab Exposure Associates with Radiologic Evidence of Healing in Patients with Crohn's Disease.

Clin Gastroenterol Hepatol. 2021 Aug;19(8):1573-1582.e5.
High-Dose Vitamin D Does Not Prevent Postoperative Recurrence of Crohn's Disease in a Randomized Placebo-Controlled Trial.

Am J Gastroenterol. 2021 Jan 1;116(1):134-141.
Location but Not Severity of Endoscopic Lesions Influences Endoscopic Remission Rates in Crohn's Disease: A Post Hoc Analysis of TAILORIX.

Frontiers in Pediatrics, 05 February 2021
Health Literacy and Quality of Life in Young Adults From The Belgian Crohn's Disease Registry Compared to Type 1 Diabetes Mellitus.

Inflammatory Bowel Diseases, izab042.
Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel Diseases.

Inflammatory Bowel Diseases, izab143.
Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients With Crohn Disease: Posthoc Analysis of the LOVE-CD Study.

Clin Gastroenterol Hepatol . 2021 Nov 26; S1542-3565(21)01268-4
Steroid-Free Deep Remission at One Year Does Not Prevent Crohn's Disease Progression: Long-Term Data From the TAILORIX Trial

United European Gastroenterol J., 2021;9:1136–1147
Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study

‹
1
2
3
4
5
6
›